FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Cruz, Others Question FDA on Covid-19 Vaccines for Babies

Some 18 members of Congress ask FDA 19 questions about Covid-19 vaccine safety in children under age 5.

Human Drugs

Consider New Approach to Monitor Drug Quality

University of Kentucky researchers say FDA should consider moving to an alternate approach to monitoring drug quality rather than relying on current g...

Biologics

Last Minute Manufacturing Data Delays Novavax Vaccine

FDA delays making a decision on Novavaxs Covid-19 vaccine emergency use authorization request after the company submitted last minute manufacturing da...

Human Drugs

End Patent Thickets: Senators

A bipartisan group of six senators calls on the U.S. Patent and Trademark Office to change its policies and procedures to eliminate so-called patent t...

Human Drugs

FDA Accepts Few Labeling Changes for Propecia

FDA orders some Propecia labeling changes sought in a 2017 petition and denies most of the other changes sought.

FDA General

House Passes User Fee/FDA Amendments Bill

The U.S. House of Representatives votes 392 to 28 to pass the Food and Drug Amendments of 2022), which would reauthorize FDA user fee programs for pre...

Medical Devices

GE Ventilator Backup Battery Class 1 Recall

FDA sets a Class 1 designation on a recall of GE Healthcares ventilator batteries used in certain Carescape R860 Ventilators.

Federal Register

4 Advisory Committees Renewed for 2 Years

Federal Register notices: FDA renews the charters for four advisory committees for an additional two years.

Federal Register

Info Collection on New Animal Drug Submissions

Federal Register notice: FDA sends to OMB an information collection extension entitled New Animal Drug Applications and Veterinary Master Files.

Biologics

Superior Response in Covid Omicron Booster: Moderna

Moderna says its bivalent Covid vaccine booster specifically targeting the Omicron variant achieved superior antibody response against Omicron and cou...